Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children

Abroad (travel likely)RecruitingPHASE2

Conditions

Recurrent Medulloblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Sanbo Brain Hospital, Beijing, China
Contact: Study coordinator (Jun-ping Zhang) · doczhjp@hotmail.com · 86+010-62856783

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

High Grade Glioma · Diffuse Intrinsic Pontine Glioma · Recurrent Medulloblastoma

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Washington D.C., United States

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

High Grade Glioma · Meningioma · Embryonal Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Aurora, United States · Cincinnati, United States

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Solid Tumor Cancer · Medulloblastoma · High Risk Neuroblastoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Boadilla del Monte, Spain

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Glioma · Medulloblastoma · Ependymoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States